[go: up one dir, main page]

WO2010027217A3 - Composition for preventing or treating alopecia caused by a chemotherapeutic agent - Google Patents

Composition for preventing or treating alopecia caused by a chemotherapeutic agent Download PDF

Info

Publication number
WO2010027217A3
WO2010027217A3 PCT/KR2009/005018 KR2009005018W WO2010027217A3 WO 2010027217 A3 WO2010027217 A3 WO 2010027217A3 KR 2009005018 W KR2009005018 W KR 2009005018W WO 2010027217 A3 WO2010027217 A3 WO 2010027217A3
Authority
WO
WIPO (PCT)
Prior art keywords
chemotherapeutic agent
composition
preventing
treating alopecia
alopecia caused
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2009/005018
Other languages
French (fr)
Korean (ko)
Other versions
WO2010027217A2 (en
WO2010027217A9 (en
Inventor
홍준표
권오병
김원철
임선묵
박민선
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daewoong Co Ltd
Original Assignee
Daewoong Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daewoong Co Ltd filed Critical Daewoong Co Ltd
Publication of WO2010027217A2 publication Critical patent/WO2010027217A2/en
Publication of WO2010027217A3 publication Critical patent/WO2010027217A3/en
Publication of WO2010027217A9 publication Critical patent/WO2010027217A9/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1808—Epidermal growth factor [EGF] urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention relates to a topically applicable composition for preventing or treating alopecia caused by a chemotherapeutic agent, including a nanoliposome consisting of a liposome layer containing a lecithin, wherein the nanoliposome includes an epidermal growth factor. In addition, the present invention relates to a pharmaceutical combination which contains the above-described composition and chemotherapeutic agent such that the composition and the chemotherapeutic agent can be individually administered.
PCT/KR2009/005018 2008-09-08 2009-09-04 Composition for preventing or treating alopecia caused by a chemotherapeutic agent Ceased WO2010027217A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020080088475A KR101503461B1 (en) 2008-09-08 2008-09-08 Composition for preventing or treating chemotherapeutic agent induced alopecia
KR10-2008-0088475 2008-09-08

Publications (3)

Publication Number Publication Date
WO2010027217A2 WO2010027217A2 (en) 2010-03-11
WO2010027217A3 true WO2010027217A3 (en) 2010-06-24
WO2010027217A9 WO2010027217A9 (en) 2010-08-12

Family

ID=41797669

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2009/005018 Ceased WO2010027217A2 (en) 2008-09-08 2009-09-04 Composition for preventing or treating alopecia caused by a chemotherapeutic agent

Country Status (3)

Country Link
KR (1) KR101503461B1 (en)
TW (1) TW201014614A (en)
WO (1) WO2010027217A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101874780B (en) * 2010-05-31 2014-01-01 沈阳药科大学 A preparation method for improving liposome encapsulation efficiency
KR20130077778A (en) * 2011-12-29 2013-07-09 서울대학교산학협력단 Composition comprising catagen or telogen inducing agents for preventing alopecia induced by cancer therapy and method for preventing alopecia using the same
JP2016132630A (en) * 2015-01-19 2016-07-25 サンスター株式会社 Oleuropein-containing composition

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834016A (en) * 1996-04-04 1998-11-10 Cilag Ag Liposome-based topical vitamin D formulation
US6113889A (en) * 1996-02-15 2000-09-05 Societe L'oreal S.A. Screening of candidates for biological hair care activity
JP2004284968A (en) * 2003-03-20 2004-10-14 Bio Igaku Kenkyusho Kk Skin external preparation
KR20070101426A (en) * 2006-04-10 2007-10-17 주식회사 대웅 Nanoliposome using esterified lecithin

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6113889A (en) * 1996-02-15 2000-09-05 Societe L'oreal S.A. Screening of candidates for biological hair care activity
US5834016A (en) * 1996-04-04 1998-11-10 Cilag Ag Liposome-based topical vitamin D formulation
JP2004284968A (en) * 2003-03-20 2004-10-14 Bio Igaku Kenkyusho Kk Skin external preparation
KR20070101426A (en) * 2006-04-10 2007-10-17 주식회사 대웅 Nanoliposome using esterified lecithin

Also Published As

Publication number Publication date
TW201014614A (en) 2010-04-16
WO2010027217A2 (en) 2010-03-11
KR101503461B1 (en) 2015-03-18
WO2010027217A9 (en) 2010-08-12
KR20100029634A (en) 2010-03-17

Similar Documents

Publication Publication Date Title
WO2007064857A3 (en) Amphoteric liposome formulation
WO2010002586A3 (en) Topical compositions comprising isonicotinamide
EP2219616A4 (en) Lyophilized pharmaceutical composition with improved stability containing taxane derivatives, and method of manufacturing the same
CA2713555C (en) Topical compositions and methods for whitening skin
WO2007090068A3 (en) Cyanoisoquinoline compounds that stabilize hypoxia inducible factor (hif)
WO2008042973A3 (en) Lipid containing formulations
WO2009047644A3 (en) Method of treating vitamin d insufficiency and deficiency
WO2009129246A3 (en) Compositions and methods for preparing and using same
WO2007127158A3 (en) Modification of percutaneous absorption of topically active materials
WO2010013110A3 (en) Composition comprising estrone and hydrocortisone for use in the topical treatment of baldness
WO2007099377A3 (en) Cancer treatments
WO2012078633A8 (en) Methods of inhibiting metastasis from cancer
EA033311B1 (en) Benzoxaborole derivatives as antibacterial agents
WO2009055568A3 (en) Liposomal vancomycin formulations
WO2010072958A3 (en) Topical pharmaceutical composition containing a water-sensitive active principle
WO2011100975A3 (en) Stabilized tacrolimus composition
WO2009148954A3 (en) Tpo mimetic peptide for preventing hematological disorder associated with cancer treatment
WO2013178965A3 (en) Active ingredients activating mitophagy in skin cells and use of same for improving skin condition
WO2010043717A3 (en) Pharmaceutical topical compositions
WO2012158672A3 (en) Compounds for use in treatment of mucositis
WO2012050393A3 (en) Novel compound of a reverse-turn mimetic and a production method and use therefor
WO2010063673A3 (en) Novel cosmetic compositions having hair growth inhibiting effect
WO2010021934A3 (en) Azaindole inhibitors of iap
WO2011098505A3 (en) Cosmetic preparation having a content of acyl arginates
WO2012058675A3 (en) Zinc oxide complexes

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09811716

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09811716

Country of ref document: EP

Kind code of ref document: A2